| __timestamp | Bristol-Myers Squibb Company | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5699000000 | 9335772 |
| Thursday, January 1, 2015 | 5001000000 | 12390000 |
| Friday, January 1, 2016 | 5002000000 | 25602000 |
| Sunday, January 1, 2017 | 4849000000 | 21262000 |
| Monday, January 1, 2018 | 4551000000 | 28430000 |
| Tuesday, January 1, 2019 | 4871000000 | 40849000 |
| Wednesday, January 1, 2020 | 7661000000 | 60210000 |
| Friday, January 1, 2021 | 7690000000 | 83664000 |
| Saturday, January 1, 2022 | 7814000000 | 104097000 |
| Sunday, January 1, 2023 | 7772000000 | 106916000 |
| Monday, January 1, 2024 | 8414000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of biopharmaceuticals, understanding the financial strategies of industry leaders is crucial. Bristol-Myers Squibb Company, a titan in the field, has consistently demonstrated robust financial management. From 2014 to 2023, their Selling, General, and Administrative (SG&A) expenses have shown a steady increase, peaking at approximately $7.8 billion in 2022. This represents a 37% rise from their 2014 figures, reflecting strategic investments in marketing and administration.
Conversely, Iovance Biotherapeutics, Inc., a burgeoning player, has seen its SG&A expenses grow exponentially, from under $10 million in 2014 to over $106 million in 2023. This staggering increase of over 1,000% underscores their aggressive expansion and commitment to innovation. As these companies navigate the complexities of the biopharma sector, their SG&A trends offer a window into their strategic priorities and market positioning.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
Bristol-Myers Squibb Company or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Bristol-Myers Squibb Company or Catalent, Inc.: Who Manages SG&A Costs Better?
Bristol-Myers Squibb Company or Dr. Reddy's Laboratories Limited: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Supernus Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Bristol-Myers Squibb Company vs Evotec SE: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?